Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27426 | 230 | 36.7 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
49 | 3 | ALZHEIMERS DISEASE//AMYOTROPHIC LATERAL SCLEROSIS//DEMENTIA | 92146 |
699 | 2 | AMYOTROPHIC LATERAL SCLEROSIS//FRONTOTEMPORAL DEMENTIA//ALS | 13006 |
27426 | 1 | RILUZOLE//PK 26124//1 METHYL 4 PHENYLPYRIDIUM | 230 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RILUZOLE | authKW | 5013302 | 52% | 32% | 119 |
2 | PK 26124 | authKW | 265525 | 1% | 100% | 2 |
3 | 1 METHYL 4 PHENYLPYRIDIUM | authKW | 132762 | 0% | 100% | 1 |
4 | 2 AMINO 6 TRIFLUOROMETHOXY BENZOTHIAZOLE | authKW | 132762 | 0% | 100% | 1 |
5 | 2 AMINO 6 TRIFLUOROMETHOXY BETIZOTHIAZOLE | authKW | 132762 | 0% | 100% | 1 |
6 | 2 AMINOBENZOXAZOLE DERIVATIVES | authKW | 132762 | 0% | 100% | 1 |
7 | ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONIC ACID ANTAGONIST | authKW | 132762 | 0% | 100% | 1 |
8 | ALPHA AMINO 3 HYDROXY 5 METHYLISOXASOLE 4 PROPIONATE | authKW | 132762 | 0% | 100% | 1 |
9 | ALPHA AND BETA SCORPION VENOM | authKW | 132762 | 0% | 100% | 1 |
10 | ANTAGONISTS GLUTAMATE RILUZOLE | authKW | 132762 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 1159 | 42% | 0% | 96 |
2 | Pharmacology & Pharmacy | 711 | 33% | 0% | 77 |
3 | Clinical Neurology | 238 | 15% | 0% | 35 |
4 | Anesthesiology | 83 | 4% | 0% | 9 |
5 | Psychiatry | 14 | 4% | 0% | 9 |
6 | Chemistry, Medicinal | 9 | 3% | 0% | 6 |
7 | Biochemical Research Methods | 5 | 3% | 0% | 6 |
8 | Chemistry, Analytical | 4 | 3% | 0% | 8 |
9 | Toxicology | 2 | 2% | 0% | 4 |
10 | Critical Care Medicine | 2 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CREAT INITIAT STUDY CENT NERVOUS SYST ZIN | 132762 | 0% | 100% | 1 |
2 | DENT ANESTHESIOL I CLIN MED SCIMINAMI KU | 132762 | 0% | 100% | 1 |
3 | DENT PHARMACOL INTEGRATED MED SCIMINAMI | 132762 | 0% | 100% | 1 |
4 | E FLOOR MED QUEENS MED | 132762 | 0% | 100% | 1 |
5 | HOLLY MARY TECHNOL SCI | 132762 | 0% | 100% | 1 |
6 | KLIN NEUROZENTRUM | 132762 | 0% | 100% | 1 |
7 | MEDTAC MRRC | 132762 | 0% | 100% | 1 |
8 | NALANDA EDUC SOC KANTEPUDI | 132762 | 0% | 100% | 1 |
9 | NEUROBIOL SECTOR SPINAL | 132762 | 0% | 100% | 1 |
10 | NEUROL EARCHING | 132762 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMYOTROPHIC LATERAL SCLEROSIS | 1635 | 1% | 0% | 3 |
2 | NEUROSCIENCE LETTERS | 1219 | 7% | 0% | 17 |
3 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1194 | 7% | 0% | 16 |
4 | NEUROPHARMACOLOGY | 897 | 3% | 0% | 8 |
5 | CNS NEUROSCIENCE & THERAPEUTICS | 719 | 1% | 0% | 2 |
6 | AKTUELLE NEUROLOGIE | 664 | 1% | 0% | 3 |
7 | PHARMACOLOGICAL REPORTS | 662 | 1% | 0% | 3 |
8 | CELL JOURNAL | 368 | 0% | 0% | 1 |
9 | DRUGS OF TODAY | 329 | 1% | 0% | 2 |
10 | NEUROREPORT | 280 | 2% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BELLINGHAM, MC , (2011) A REVIEW OF THE NEURAL MECHANISMS OF ACTION AND CLINICAL EFFICIENCY OF RILUZOLE IN TREATING AMYOTROPHIC LATERAL SCLEROSIS: WHAT HAVE WE LEARNED IN THE LAST DECADE?.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 17. ISSUE 1. P. 4 -31 | 57 | 31% | 94 |
2 | CHEAH, BC , VUCIC, S , KRISHNAN, AV , KIERNAN, MC , (2010) RILUZOLE, NEUROPROTECTION AND AMYOTROPHIC LATERAL SCLEROSIS.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 18. P. 1942-1959 | 58 | 29% | 90 |
3 | GRANT, P , SONG, JY , SWEDO, SE , (2010) REVIEW OF THE USE OF THE GLUTAMATE ANTAGONIST RILUZOLE IN PSYCHIATRIC DISORDERS AND A DESCRIPTION OF RECENT USE IN CHILDHOOD OBSESSIVE-COMPULSIVE DISORDER.JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. VOL. 20. ISSUE 4. P. 309-315 | 27 | 59% | 24 |
4 | PITTENGER, C , CORIC, V , BANASR, M , BLOCH, M , KRYSTAL, JH , SANACORA, G , (2008) RILUZOLE IN THE TREATMENT OF MOOD AND ANXIETY DISORDERS.CNS DRUGS. VOL. 22. ISSUE 9. P. 761 -786 | 50 | 30% | 65 |
5 | AHN, HS , CHOI, JS , CHOI, BH , KIM, MJ , RHIE, DJ , YOON, SH , JO, YH , KIM, MS , SUNG, KW , HAHN, SJ , (2005) INHIBITION OF THE CLONED DELAYED RECTIFIER K+ CHANNELS, KV1.5 AND KV3.1, BY RILUZOLE.NEUROSCIENCE. VOL. 133. ISSUE 4. P. 1007-1019 | 25 | 66% | 23 |
6 | ZARATE, CA , MANJI, HK , (2008) RILUZOLE IN PSYCHIATRY: A SYSTEMATIC REVIEW OF THE LITERATURE.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 4. ISSUE 9. P. 1223-1234 | 30 | 40% | 32 |
7 | DOBLE, A , (1996) THE PHARMACOLOGY AND MECHANISM OF ACTION OF RILUZOLE.NEUROLOGY. VOL. 47. ISSUE 6. P. S233-S241 | 19 | 70% | 213 |
8 | YOSHIDA, M , NOGUCHI, E , TSURU, N , OHKOSHI, N , (2001) EFFECT OF RILUZOLE ON THE ACQUISITION AND EXPRESSION OF AMYGDALA KINDLING.EPILEPSY RESEARCH. VOL. 46. ISSUE 2. P. 101-109 | 21 | 68% | 6 |
9 | BRYSON, HM , FULTON, B , BENFIELD, P , (1996) RILUZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN AMYOTROPHIC LATERAL SCLEROSIS.DRUGS. VOL. 52. ISSUE 4. P. 549-563 | 26 | 54% | 118 |
10 | GILGUN-SHERKI, Y , PANET, H , MELAMED, E , OFFEN, D , (2003) RILUZOLE SUPPRESSES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS: IMPLICATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS.BRAIN RESEARCH. VOL. 989. ISSUE 2. P. 196-204 | 24 | 49% | 58 |
Classes with closest relation at Level 1 |